Related Experiment Video
Updated: Jun 19, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Models of antigen receptor activation in the design of vaccines
Eszter Molnár1, Elaine-Pashupati Dopfer, Sumit Deswal
1Max Planck-Institute for Immunobiology and University of Freiburg, Stübeweg 51, 79108 Freiburg, Germany.
Abstract:
Vaccination techniques have developed rapidly over the last several decades from the immunization with live attenuated pathogens to the use of peptide and DNA subunit vaccines, from the use of classical adjuvants to cell-directed delivery. Vaccination techiques are also under investigation for the treatment of tumors and autoimmune diseases. However, profound knowledge of activation mechanisms of the immune cells on a molecular level is prerequisite for a better understanding of the immune response, and for the development of effective immunomodulatory tools. In this review we discuss the models of BCR and TCR activation, and using the example of some vacciantion technologies, we show, how the understanding of these models could help in the design of a new generation of vaccines.
Insights
This review explores advancements in vaccination, from live pathogens to subunit vaccines, and their potential for treating cancer and autoimmune diseases. Understanding immune cell activation is key to developing next-generation vaccines.
Area of Science:
- Immunology and vaccine development.
- Molecular mechanisms of immune cell activation.
- Therapeutic applications of vaccines.
Background:
- Vaccination techniques have evolved significantly, encompassing live attenuated pathogens, peptide, DNA subunit vaccines, and cell-directed delivery systems.
- Current research explores vaccine applications for treating tumors and autoimmune diseases.
- A deep understanding of molecular-level immune cell activation is crucial for advancing vaccine efficacy.
Purpose of the Study:
- To review models of B-cell receptor (BCR) and T-cell receptor (TCR) activation.
- To demonstrate how understanding these activation models can inform the design of novel vaccines.
- To highlight the role of molecular insights in developing effective immunomodulatory tools.
Main Methods:
- Review of existing literature on BCR and TCR activation pathways.
- Analysis of current vaccination technologies and their underlying immunological principles.
- Integration of molecular activation models with vaccine design strategies.
Main Results:
- Discussion of established models for BCR and TCR activation.
- Illustrative examples of how understanding these models aids vaccine design.
- Emphasis on the link between molecular mechanisms and immunomodulatory potential.
Conclusions:
- Understanding BCR and TCR activation at a molecular level is fundamental for rational vaccine design.
- This knowledge facilitates the development of a new generation of targeted and effective vaccines.
- Future vaccine strategies can be optimized by leveraging insights into immune cell signaling pathways.
More Related Videos
Related Concept Videos
Vaccines
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Vaccinations
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

